Legend Biotech director Robin Meng files Form 3

Legend Biotech Corp filed an initial insider ownership report for director Robin Meng on Form 3.

Accepted by SEC EDGAR 03/18/2026 - 07:02 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Legend Biotech Corp filed an initial insider ownership report for director Robin Meng on Form 3. This filing establishes Meng’s status as a reporting insider but shows no reported transactions or holdings, indicating that only insider status, not trading activity, is being disclosed at this time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Legend Biotech (LEGN) Form 3 for Robin Meng show?

The Form 3 for Legend Biotech director Robin Meng reports their status as an insider. It shows no reported transactions or derivative positions, indicating this filing is an initial ownership statement without disclosed trading activity or current holdings in the excerpt provided.

Did Robin Meng buy or sell Legend Biotech (LEGN) shares in this Form 3?

No transactions are reported for Robin Meng in this Form 3. The transaction summary lists zero buys, zero sells, and no derivative exercises, so the filing only records insider status rather than any recent trading in Legend Biotech shares.

What insider role does Robin Meng hold at Legend Biotech (LEGN)?

Robin Meng is identified as a director of Legend Biotech Corp in the Form 3. The filing marks them as a director, with no officer role or ten percent owner status, establishing their reporting obligations as a board member under SEC insider ownership rules.

Are there any derivative securities reported for Robin Meng at Legend Biotech (LEGN)?

No derivative securities are reported for Robin Meng in this Form 3. The derivativeSummary section is empty and derivativeTransactionCount is zero, indicating no options, warrants, or other derivative positions are disclosed in this particular filing excerpt.

What does a zero holding entry mean in the Legend Biotech (LEGN) Form 3?

A zero holding entry means the Form 3 excerpt shows no specific share or derivative holdings for Robin Meng. HoldingEntries is zero, so the filing focuses on establishing insider status without detailing any current ownership amounts in this visible portion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meng Robin

(Last)

(First)

(Middle)

C/O LEGEND BIOTECH CORP

2101 COTTONTAIL LANE

(Street)

SOMERSET

NEW JERSEY

08873

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Legend Biotech Corp [ LEGN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ James Pepin, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR